293results about "Platinum organic compounds" patented technology

The present disclosure includes compounds, compositions, and methods for nucleic acid amplification reactions. In particular, the present disclosure provides compounds, compositions, and methods for viability PCR (vPCR) applications, in which the compounds that selectively bind to nucleic acids from non-viable cells.

Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.

A light-receiving device in which an increase in driving voltage is inhibited is provided. Any of the following light-receiving devices is provided: a light-receiving device that includes a light-receiving layer between a pair of electrodes and in which the light-receiving layer includes an active layer, a buffer layer, and an electron-transport layer, the buffer layer is between the active layer and the electron-transport layer and is in contact with the active layer, and the buffer layer includes an organic compound having an electron-withdrawing group; a light-receiving device that includes a light-receiving layer between a pair of electrodes and in which the light-receiving layer includes an active layer, a buffer layer, and an electron-transport layer, the buffer layer is between the active layer and the electron-transport layer and is in contact with the active layer, and the buffer layer includes a heteroaromatic compound having an electron-withdrawing group.

A compound having a first ligand LA comprising a structure of Formula I,is provided. In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X6 is C or N; Y is a linking group; K is a direct bond or a linking group; each substituent is hydrogen or a General Substituent defined herein; and at least one of the following conditions is true: (1) an RA substituent is joined with an RB substituent to form a ring AB, which may be substituted by one or more RAB substituents; or (2) X5 and X6 are C, and the corresponding two RA substituents are joined to form a cyclic moiety A1, which may be substituted by one or more RA1 substituents; and moiety B is a polycyclic fused ring system. Formulations, OLEDs, and consumer products containing the compound are also provided.

Provided is a compound including a metal complex having a metal M with a coordination number of four with four coordinating atoms, Z1, Z2, Z3, and Z4, coordinated to the metal M. In the compound, each of Z1, Z2, Z3, and Z4 is independently selected from O, S, Se, N, P, C, Si, or B; at least one of Z1, Z2, Z3, or Z4 is S* or Se*, where S* and Se* represent S or Se, respectively, that form a dative bond with M; and the metal M is selected from Pt, Pd, Cu, Ag, Au, or Zn, Formulations, OLEDs, and consumer products containing the compound are also provided.

The invention relates to the technical field of graded screening, in particular to a graded screening system based on staggered stacked metal ring films and a preparation method and application. An organic ligand and two metal complexes are subjected to interface coordination assembly under the action of silver ions, an ordered staggered stacked metal ring film is constructed, the structure and performance of the metal ring film are precisely regulated and controlled, the metal ring film has a definite molecular sieve component difference, and then precise grading screening of different molecules is achieved. The film has an obvious lattice structure, has good crystalline orderliness, and can ensure the stability and reliability of the screening process. The graded screening system based on the staggered stacked metal ring membranes has excellent interception performance on target molecules, and effective separation of TAC from glucan and leucine can be achieved. The two-stage membrane classification screening strategy can also be popularized to separation and purification of other substances, and good universality and industrial application prospects are achieved.

The invention relates to organic electroluminescent materials and devices. There is provided a compound having a first ligand LA having a structure of Formula I wherein consecutive two of X1 to X8 are C and bonded to the structure of Formula II in Formula I, Part A is a monocyclic or polycyclic fused ring system; each of Z1 to Z2 and X1 to X12 is C or N; each of Y1 and Y2 is a linking group; k is a direct bond or a linking group; each substituent is hydrogen or a universal substituent as defined herein; and LA is coordinated with the metal M. Also provided is a compound having the formula Ir (LA *) x (LB *) y (LC *) z as defined herein. Formulations, OLEDs and consumer products containing these compounds are further provided.

Provided are an organometallic compound, a light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device. The light-emitting device includes a first electrode, a second electrode facing the first electrode, and an interlayer disposed between the first electrode and the second electrode. The interlayer includes an emission layer. The emission layer includes a first compound which is the organometallic compound; and a second compound, a third compound, a fourth compound, or any combination thereof. The first compound, the second compound, the third compound, and the fourth compound are different from one another.

The invention discloses a platinum (IV)-pirfenidone compound prodrug, a preparation method and microenvironment remodeling anti-tumor application, and belongs to the field of medical technology and drug synthesis. A series of molecules are characterized by being platinum prodrugs modified by pirfenidone derivatives. The synthesis method sequentially comprises the following steps: oxidizing platinum drugs, modifying hydroxyl groups, and introducing pirfenidone derivatives through esterification reaction. A series of molecules are reduced into Pt (II) drugs at the focus to kill cancer cells, and meanwhile, the released pirfenidone derivative can remodel the tumor microenvironment. The platinum prodrug disclosed by the invention not only has excellent cancer cell killing ability, but also is relatively low in drug resistance and excellent in safety, can trigger immunogenic cell death, and is a brand new chemotherapy-immunotherapy method. A series of molecules are convenient to synthesize, the preparation process is simple, and the amphipathicity is excellent, the anti-cancer capability is excellent, the drug resistance and toxicity are low, and the clinical application prospect is good.

The invention relates to organic electroluminescent materials and devices. There is provided a compound having a first ligand LA comprising a structure of Formula I in which each of moieties A and B is a monocyclic or polycyclic fused ring system; at least one RA or RB has the structure of formula II, wherein the dashed line represents a bond to part A or part B, respectively; the part D is a polycyclic fused ring system; each of Z1 to Z4 and X1 to X5 is C or N; l is a direct bond or a linking group; y is a linking group; each of K1 and K2 is a direct bond or a linking group; and the dashed line of formula I is coordinated with the metal M. Formulations, OLEDs, and consumer products containing the compounds are also provided.

A light-emitting device includes a first electrode, a second electrode opposite to the first electrode, an interlayer between the first electrode and the second electrode, and an organometallic compound represented by Formula 1. In addition, there are provided an electronic apparatus and electronic equipment each including the light-emitting device, and the organometallic compound represented by Formula 1.

The present invention relates to the technical field of organic light-emitting materials, and provides a tetradentate cyclometalated platinum (II) complex based on an oxygen atom linkage and containing phenyl acridine and an application thereof. The tetradentate cyclometalated platinum (II) complex has the structure as represented by general formula (I). (I) The cyclometalated platinum (II) complex in the present invention adopts a tetradentate ligand, is high in rigidity, and can improve the light stability of a light-emitting material. At the same time, the complex molecule can strongly emit light, and therefore can be used as a light-emitting material in an OLED device.

Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same. In Formula 1, M1 is a transition metal, L11 is a ligand represented by Formula 1-1, L12 is an organic ligand, n11 is 1, n12 is 0, 1, or 2, and descriptions for other substituent are provided in the specification:         Formula 1     M1(L11)n11(L12)n12

Tetradentate platinum complexes including an imidazole / benzimidazole carbene having a structure of Formula Iis disclosed. In Formula I, M is Pd or Pt. These platinum carbenes with the specific substituents disclosed herein are novel and provides phosphorescent emissive compounds that exhibit physical properties that can be tuned, such as sublimation temperature, emission color, and device stability.

Provided are organometallic compounds of of Formula I:Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

A novel organometallic complex and a novel light-emitting device are provided. An organometallic complex represented by General Formula (G1) is provided. Note that in General Formula (G1), each of Z1, Z2, Z3, and Z4 independently represents carbon or nitrogen, and at least one of them represents nitrogen. When any of Z1, Z2, Z3, and Z4 represents carbon, the carbon has hydrogen (including deuterium) or a substituent, and the substituent is any one of an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a silyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, and a cyano group. Each of R1 to R18 independently represents any one of hydrogen (including deuterium), an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a silyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, and a cyano group.

The present invention is a composition comprising a) a compound functionalized with at least one Si-H group; b) a compound functionalized with at least one olefin group; and c) compound of Formula 1: where x, R1, R2, and R3 are as defined herein. The composition provides a pre-catalyst that decomposes quickly to a platinum state that promotes hydrosilylation upon irradiation with light of the appropriate wavelength.

An organometallic compound is represented by Formula 1. An organic light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer and at least one of the organometallic compound represented by Formula 1. An apparatus includes the organic light-emitting device.

The present invention relates to metal complexes which are substituted by aromatic and bicydic aliphatic substituents and are suitable for use as emitters in organic electroluminescent devices. The electronic devices of the invention, especially organic electroluminescent devices, are notable for advantages that are not accompanied by a deterioration in the further electronic properties. The invention provides a compound of the following formula (1):wherein B is a group of the following formula (2):

The application provides a kind of green phosphorescent dopant material and its preparation method, organic electroluminescent device and organic electroluminescent device, the structural general formula of the green phosphorescent dopant material is chemical formula I, the green phosphorescent dopant material of the application introduces the OCN four-tooth ligand structure containing platinum, can effectively improve the stability of compound, further connects silane group on the parent core, the group has huge steric hindrance, hinders the close approach between Pt complex core plane, effectively weakens intermolecular pi-pi stacking effect, significantly reduces concentration quenching effect, more helps to improve carrier capture efficiency, improves device efficiency.The material of the application can obtain the device with higher luminous efficiency and longer service life while maintaining low driving voltage.

This application relates to organic electroluminescent materials and devices. The invention includes novel heterocyclic materials suitable for use as blue phosphorescent materials in OLED devices. The novel materials include two fused 5-membered aromatic or pseudoaromatic rings that combine with a 6-membered aromatic ring to act as chelating ligands for transition metals. The novel materials are computationally determined to have suitable triplet energies for use as blue emitters and have sufficient chemical stability for use in devices.

Provided is a Pt(IV) complex. As a prodrug, the Pt(IV) complex is activated by irradiation to release a Pt(II) complex for the treatment of tumors. Also provided is a pharmaceutical composition including the Pt(IV) complex, and the use of the Pt(IV) complex in the preparation of a drug for treating tumors by means of irradiation activation. Further provided is a kit including the Pt(IV) complex and the description, wherein the description indicates that radiotherapy is performed after administration to treat tumors.

A compound is described as having a triplet excited state and a singlet excited state; wherein the triplet excited state comprises a lowest energy triplet sublevel, a middle energy triplet sublevel, and a highest energy triplet sublevel; and wherein an energy separation between the highest energy triplet sublevel and the lowest energy triplet sublevel (ZFS) is greater than an energy separation between the singlet excited state and a the lowest energy triplet sublevel. Also described is a compound represented by the following Formula I. These compounds should find application as luminescent materials in organic light emitting diodes (OLEDs).

The present disclosure relates to a metal complex and use thereof. The metal complex has a structure as shown in a formula (1). The metal complex provided by the present disclosure has advantages of good optical, electrical and thermal stability, high luminous efficiency, long service life, high color saturation and the like, can be used in an organic light-emitting device, particularly can be used as a green light-emitting phosphorescent material, and is possible to be used in the active-matrix organic light-emitting diode (AMOLED) industry.

Embodiments provide an organometallic compound, a light-emitting device including the organometallic compound, an electronic apparatus including the light-emitting device, and electronic equipment including the light-emitting device. The light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and the organometallic compound. The organometallic compound is represented by Formula 1, which is explained in the specification:

The application discloses a tetravalent platinum ester alkyne complex, a degradable high polymer, a nanomicelle and a preparation method and application thereof; the structural formula of the tetravalent platinum ester alkyne complex is shown as formula (I); the preparation method of the degradable high polymer is as follows: the tetravalent platinum ester alkyne complex is prepared first; then the obtained tetravalent platinum ester alkyne complex and diamine and monomethyl ether polyethylene glycol mPEG-NH2 are clicked to obtain a triblock high polymer. The nanomicelle of the degradable high polymer is also disclosed. The tetravalent platinum ester alkyne complex disclosed by the application can specifically respond to reducing substances in a tumor microenvironment, and the enamine ester structure generated by the reaction of the tetravalent platinum ester alkyne complex with diamine also has the property of responding to an acidic environment; the high polymer has mild and simple preparation conditions, the molecular weight can reach 35200, and the platinum drug loading capacity is as high as 33.91%; the nanomicelle can efficiently degrade and release anticancer active drugs in the tumor microenvironment, and has high antitumor activity and low cytotoxicity.

The present invention belongs to the field of organic electroluminescence, and specifically relates to a tetradentate cyclometalated platinum (II) complex guest phosphorescent material based on a 2,3',5'-substituted 1,1'-biphenyl structure and the use thereof. In the present invention, by introducing alkyl or aryl to the positions 2, 3' and 5' of 1,1'-biphenyl to increase the steric hindrance, red shift or luminescence quenching caused by molecular aggregation can be avoided. Deuteration at the periphery of a cyclometalating ligand can improve the stability of the material, so that the phosphorescent material provided by the present invention has good chemical stability and thermal stability and can be easily used for manufacturing evaporation-type OLED devices. Organic electroluminescent devices manufactured by using the complex of the present invention as a light-emitting layer material have significant improvement in both current efficiency and service lifetime, thereby achieving great application prospects in the fields of OLED display and illumination.

The present invention provides organometallic compounds, as well as OLEDs and related consumer products that utilize these organometallic compounds. [Solution] The following ligand L A Organometallic compounds containing the following are provided. TIFF2026065028000224.tif62170 Said ligand L A It forms a complex with metal M via two dashed lines; M is Ru, Os, Ir, Pd, Pt, Cu, Ag, or Au, and can coordinate with other ligands; the ligand L A It can combine with other ligands to form tridentate, quadridentate, quindentate, or hexadentate ligands.